By Nigam Arora & Dr. Natasha Arora
TXN stock has dropped about 10% and is trading at $192.70 as of this writing in the premarket. It has traded as low as $187.90 in the premarket.
Analog Semiconductors
TXN is a leading analog semiconductor company that supplies power management chips for Nvidia’s (NVDA) Blackwell chip. TXN chips are used in AI, automotive, and industrial sectors.
Partial Profits
Partial profits were taken before the stock dropped. TXN was trading at $217.45 when the signal to take partial profits was given. This shows the power of The Arora Report system to take partial profits. For more, please see the Trade Management Guidelines.
Earnings
TXN reported earnings better than the consensus but less than whisper numbers. The company also guided lower.
Zones
For those following the Good Way, the Buy Now rating is *** (To see the locked content, please take a 30 day free trial).
For those following the Best Way, the buy zone to scale in is $*** – $***.
The maximum recommended quantity is ***%.
The first target zone is $*** – $***.
The very long term second target zone remains $276 – $283.
This is a very long term position.
What To Do Now
Those in TXN may consider holding or adding following the parameters given above.
Those not in TXN may consider following the parameters given above.
Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 1% of the content from our paid services. …TO RECEIVE REMAINING 99%, INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES AND SIGNALS IN REAL TIME, TAKE A FREE
TRIAL TO PAID SERVICES.
The Arora Report is one of the only major global investment newsletters that does not employ a single salesperson—because it does not need to. While competitors rely on high-pressure sales tactics, The Arora Report grows purely through results, with satisfied members recommending it to their family and friends.
Join the service that investors trust the most and recommend to family and friends.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
